The Plavix lawsuit dates back to 2014, when Hawaii first sued BMS and Sanofi, alleging that they failed to properly inform ...

Hawaii said on Friday it entered a $700 million settlement with pharmaceutical firm Bristol-Myers Squibb and units of French ...

Bristol-Myers Squibb will pay $350 million to settle Hawaii's lawsuit over Plavix marketing practices, ending claims without ...

The Department of Attorney General of Hawaii announced that Bristol-Myers Squibb (NYSE:BMY) and three units of Sanofi (NASDAQ ...

HPR's Ashley Mizuo reports on the settlement between two pharmaceutical companies, Sanofi and Bristol Myers Squibb in the ...

Hawaii will receive $700 million from pharmaceutical giants Bristol Myers Squibb and Sanofi in a landmark settlement over the ...

The settlement divides the $700 million payment equally between pharmaceutical giants Bristol Myers Squibb and Sanofi.

Pharmaceutical giants Bristol Myers Squibb and Sanofi have agreed to pay $700 million to Hawaii to settle a lawsuit over the efficacy and labeling of the blood thinner Plavix ...

The settlement concludes a 12-year legal battle over the efficacy of Plavix for Asian, Pacific Islander and Native Hawaiian ...

and three units of Sanofi (NASDAQ:SNY) have agreed to pay $700M to the state to resolve nearly 12 years of litigation related to the companies’ marketing of blood thinner Plavix. The lawsuit ...

Hawaii had alleged the companies violated state consumer protection laws by marketing Plavix without disclosing ... between Bristol-Myers Squibb and Sanofi, Hawaii said in a statement, adding ...

Hawaii will receive a $700 million settlement from pharmaceutical companies Bristol Myers Squibb and Sanofi over the blood ...